Afatinib in the treatment of EGFR mutation-positive NSCLC ― A network meta-analysisPOPAT, Sanjay; MOK, Tony; YANG, James Chih-Hsin et al.Lung cancer. 2014, Vol 85, Num 2, pp 230-238, issn 0169-5002, 9 p.Article

Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS)YANG, James Chih-Hsin; WU, Yi-Long; CHAN, Valorie et al.Lung cancer. 2014, Vol 83, Num 2, pp 174-181, issn 0169-5002, 8 p.Article

Impact of EGFR Inhibitor in Non―Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-AnalysisCHEE KHOON LEE; BROWN, Chris; JEMELA ANNE OSORIO SANCHEZ et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 9, pp 595-605, issn 0027-8874, 11 p.Article

Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR MutationsYANG, James Chih-Hsin; HIRSH, Vera; PALMER, Michael et al.Journal of clinical oncology. 2013, Vol 31, Num 27, pp 3342-3350, issn 0732-183X, 9 p.Article

Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopyTSAI, Tzu-Hsiu; YANG, Ching-Yao; YANG, Pan-Chyr et al.Lung cancer. 2013, Vol 82, Num 3, pp 420-425, issn 0169-5002, 6 p.Article

First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trialYANG, James Chih-Hsin; JIN HYOUNG KANG; ORLANDO, Mauro et al.European journal of cancer (1990). 2014, Vol 50, Num 13, pp 2219-2230, issn 0959-8049, 12 p.Article

ATLAS: Randomized, Double-Blind, Placebo-Controlled, Phase IIIB Trial Comparing Bevacizumab Therapy With or Without Erlotinib, After Completion of Chemotherapy, With Bevacizumab for First-Line Treatment of Advanced Non―Small-Cell Lung CancerJOHNSON, Bruce E; KABBINAVAR, Fairooz; RUBIN, Mark et al.Journal of clinical oncology. 2013, Vol 31, Num 31, pp 3926-3934, issn 0732-183X, 9 p.Article

Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancerSHAO, Yu-Yun; SHAU, Wen-Yi; LIN, Zhong-Zhe et al.European journal of cancer (1990). 2013, Vol 49, Num 1, pp 106-114, issn 0959-8049, 9 p.Article

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR MutationsSEQUIST, Lecia V; YANG, James Chih-Hsin; SU, Wu-Chou et al.Journal of clinical oncology. 2013, Vol 31, Num 27, pp 3327-3334, issn 0732-183X, 8 p.Article